Skip to main content
. 2017 Jul 22;8(41):69916–69923. doi: 10.18632/oncotarget.19455

Figure 3.

Figure 3

Sensitivity analysis of the association between SF3B1 mutation and PFS (A) / OS (B) of CLL.